Page last updated: 2024-10-27

fleroxacin and Joint Diseases

fleroxacin has been researched along with Joint Diseases in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Joint Diseases: Diseases involving the JOINTS.

Research Excerpts

ExcerptRelevanceReference
"5 and 6 h after dosing and the drug was still detectable in plasma 48 h after dosing (0."1.30Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics. ( Förster, C; Günther, T; Lozo, E; Merker, HJ; Schwabe, R; Stahlmann, R; Vormann, J; Zippel, U, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Förster, C1
Schwabe, R1
Lozo, E1
Zippel, U1
Vormann, J1
Günther, T1
Merker, HJ1
Stahlmann, R1

Other Studies

1 other study available for fleroxacin and Joint Diseases

ArticleYear
Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
    Archives of toxicology, 1997, Volume: 72, Issue:1

    Topics: Age Factors; Animals; Anti-Infective Agents; Calcium; Cartilage; Ciprofloxacin; Contraindications; F

1997